Schedule your telehealth consultation today
Hypoglycemia: Assess risk in patients taking concomitant insulin or insulin secretagogues
Your prescribing provider will set your specific dose, frequency, and cycle length based on your injury, health status, and goals
With these points in mind, we undertook a broad assessment of published clinical data, curating the body weight loss (% from baseline), glycosylated hemoglobin levels (HbA1c), and nausea responses (% patients reporting) from the SUSTAIN 3, SUSTAIN 7, SCALE Diabetes, SURPASS 2, and STEP 2 trials (17, 22, 64, 66, 67) ( Figures 1AC )
"Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials"
Starting Ozempic, Wegovy, or Mounjaro: What to Expect in the First Weeks Starting any GLP-1 therapy can bring quick appetite changes and early side effects